Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers

Blood

Volumn 102, Issue 2, 2003, Pages 577-584

  Saito, Mineki ^b   Braud, Veronique M ^b   Goon, Peter ^b   Hanon, Emmanuel ^b   Taylor, Graham P ^b   Saito, Akiko ^b   Eiraku, Nobutaka ^b   Tanaka, Yuetsu ^b   Usuku, Koichiro ^b   Weber, Jonathan N ^b   Osame, Mitsuhiro ^b   Bangham, Charles R M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; HLA E ANTIGEN; LIGAND; RECEPTOR SUBTYPE; T LYMPHOCYTE RECEPTOR; TAX PROTEIN; TETRAMER;

ANALYTIC METHOD; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CANCER PATIENT; CELL ISOLATION; CELL SUBPOPULATION; CELL TYPE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IMMUNOREGULATION; MOLECULAR CLONING; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; SYMPTOMATOLOGY; T LYMPHOCYTE; VIRUS CARRIER; VIRUS INFECTION;

EID: 0012852576     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-09-2855     Document Type: Article

References (43)

1. Poiesz BJ, Ruscetti RW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc Natl Acad Sci U S A. 1980;77:7415-7419.
2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982;79:2031-2035.
3. Hinuma Y, Nagata K, Misaka M, et al. Adult T cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981;78:6476-6480.
4. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in disease. Proc Natl Acad Sci U S A. 1984;81:2534-2537.
5. Gessain A, Barin F, Vemant JC, et al. Antibodies to human T-lmphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet. 1985;2:407-410.
6. Osame M, Usuku K, Izumo S, et al. HTLV-1 associated myelopathy, a new clinical entity. Lancet. 1986;1:1031-1032.
7. Kaplan JE, Osame M, Kubota H, et al. The risk of development of HTLV-1 associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-1. J Acquir Immune Defic Syndr. 1990;3;1096-1101.
8. Biron CA. Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol. 1997;9:24-34.
9. Fujiwara K, Itoyama Y, Yu F, Kubo C, Goto I. Cellular immune surveillance against HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neurol Sci. 1991;105:99-107.
10. Yu F, Itoyama Y, Fujiwara K, Goto I. Natural Killer (NK) cells in HTLV-1-associated myelopathy/tropical spastic paraparesis-decrease in NK cell subset populations and activity in HTLV-1 seropositive individuals. J Neurol Sci. 1991;33:121-128.
11. Moretta A, Bottino C, Vitale M, et al. Receptors for HLA-class I-molecules in human natural killer cells. Annu Rev Immunol. 1996;14:619-648.
12. + T cells. Proc Natl Acad Sci U S A. 1998;95:1172-1177.
13. + T lymphocyte subsets that express HLA-class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci U S A. 1996;93:12433-12438.
14. Biassoni R, Cantoni C, Pende D, et al. Human natural killer cell receptors and co-receptors. Immunol Rev. 2001;181:203-214.
15. + T cells infected with human T-cell lymphotropic virus type 1 (HTLV-1) is prevented by cytotoxic T lymphocytes. Blood. 2000;95:1386-1392.
16. Braud VM, Allan DS, O'Callaghan CA, et al. HLA-E binds to natural killer cell receptors CD94/ NKG2A, B and C. Nature 1998;391:795-799.
17. + T cell subsets in human T lymphotrophic virus type 1-infected individuals. J Immunol. 1998;161:6674-6680.
18. Gorski J, Yassai M, Zhu X, Kissella B, Keever C, Flomenberg N. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. J Immunol. 1994;152:5109-5119.
19. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 1998;4:586-593.
20. + T cells. Curr Opin Immunol. 2001;13:465-470.
21. + thymic or mature gammadelta T cell clones. Eur J Immunol. 1998;28:3399-3410.
22. Hanon E, Stinchcombe JC, Saito M, et al. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity. 2000;13:657-664.
23. Saito M, Taylor GP, Saito A, et al. In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes. J Virol. 2001;75:1065-1071.
24. MacDonald HR. Development and selection of NKT cells. Curr Opin Immunol. 2002;14:250-254.
25. Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med. 1993;117:1567-1573.
26. Daenke S, Kermode AG, Hall SE, et al. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. Virology. 1996;217:139-146.
27. Parker CE, Daenke SD, Nightingale S, Bangham CRM. Activated HTLV-1 specific cytotoxic T cells are found in healthy seropositives as well as patients with tropical spastic paraparesis. Virology. 1992;188:628-636.
28. + lymphocytes directly in peripheral blood of HTLV-1-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol. 1998;161:482-488.
29. Jeffery KJM, Usuku K, Hall SE, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-1) proviral load and the risk of HTLV-1-associated myelopathy. Proc Natl Acad Sci U S A. 1999;96:3848-3853.
30. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexes with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer-mediated lysis. J Exp Med. 1998;187:813-818.
31. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effecter functions. Nature. 1999;401:659-660.
32. + cells in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-1 proviral load. J Infect Dis. 2001;183:197-205.
33. Yasunaga J, Sakai T, Nosaka K, et al. Impaired production of naïve T lymphocytes in human T-cell leukemia virus type 1-infected individuals; its implications in the immunodeficient state. Blood. 2001;97:3177-3183.
34. Moser JM, Gibbs J, Jensen PE, Lukacher AE. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat Immunol. 2002;3:189-195.
35. + T cells expressing NK cell receptors in influenza A virus-infected mice. J Immunol. 2000;165:4964-4969.
36. + T cells. Nat Immunol. 2001;2:430-435.
37. Young NT, Uhrberg M. KIR expression shapes cytotoxic repertoires: a developmental program of survival. Trends Immunol. 2002;23:71-75.
38. Tendler CL, Greenberg SJ, Blattner WA, et al. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci U S A. 1990;87:5218-5222.
39. Furuya T, Nakamura T, Fujimoto T, et al. Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy. J Neuroimmunol. 1999;95:185-189.
40. Azimi N, Jacobson S, Leist T, Waldmann TA. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor. J Immunol 1999;163:4064-4072.
41. Azimi N, Nagai M, Jacobson S, Waldmann TA. IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients. Proc Natl Acad Sci U S A. 2001;98:14559-14564.
42. Garcia P, Llano M, de Heredia AB, et al. Human T cell receptor-mediated recognition of HLA-E. Eur J Immunol. 2002;32:936-944.
43. Pietra G, Romagnani C, Falco M, et al. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR α/β-mediated recognition. Eur J Immunol. 2001;31:3687-3693.